Depending on the heteromer formation, different eCBome signalling changes related to cancer can be observed, including an enhancement of CB1 signalling with GPR55 [87], inhibition of GPR55 signalling [88], and modulation of CB2 activation [89]. This evidence concerns the gene GPR55 and cancer.